Operating in a heavily regulated industry has both positives and negatives. On the positive end of things, heavy regulation is an added barrier to entry and can keep potential competitors at bay. However, as a number of health insurers discovered this week, it can also mean that your future lies in the hands of bureaucratic decisions. Follow along in the video below as Brenton Flynn outlines the news that had shares of UnitedHealth (UNH -1.61%), Humana (HUM 0.13%), and Universal American (NYSE: UAM) down hard this week.